Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …

Several breakthroughs in hepatocellular carcinoma (HCC) therapy across tumor stages
provide hope to improve its dismal prognosis. Although surgical and local ablative therapies …

Background Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a new
inclusive definition of the whole spectrum of liver diseases associated to metabolic …

Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death.
Although the burden of alcohol-and NASH-related HCC is growing, chronic viral hepatitis …

Importance Clinical data on hepatitis C virus (HCV) treatment rates in the United States are
sparse. Objective To evaluate HCV treatment rates in the era of direct-acting antivirals …

The number of effective systemic therapies for the treatment of advanced hepatocellular
carcinoma (HCC) is rapidly increasing, and the advent of immunotherapy has changed the …

Background & Aims The comparative risk of hepatocellular carcinoma (HCC) in patients with
chronic hepatitis B (CHB) receiving tenofovir disoproxil fumarate (TDF) vs. entecavir (ETV) …

The potential impact of direct-acting antivirals (DAAs) in patients with Barcelona Clinic Liver
Cancer (BCLC)-B/C hepatocellular carcinoma (HCC) is understudied. HCC patients have …

Hepatocellular carcinoma (HCC), the primary hepatic malignancy, represents the second-
highest cause of cancer-related death worldwide. Many efforts have been devoted to finding …

Following the advent of direct-acting antivirals (DAAs), hepatitis C virus (HCV) infection can
be cured in almost all infected patients. This has led to a number of clinical questions …